The Interactions Between Albendazole And Other Drugs

The clinical interactions between aspirin and a acetamiprid guanidine drugs show that this product is not susceptible to the drug reactions mediated by cytochrome P-450 in conjunction with other drugs.

Clinical trials have not yet found a significant interplay between this product and other clinical medicines.

There is no evidence that this product should be combined with other anti-tumor drugs.

Estrogen-containing therapies can reduce the efficacy of this product, it is inappropriate to share with this product

Combined with warfarin, it does not affect the pharmacokinetics of warfarin and anticoagulant activity.

In conjunction with CYP450 involved in other drugs mediated, it does not have obvious clinical inhibition.